Nice to be reminded
Conclusion: Economically, although the net profit per square centimeter of dermal template may favor IDRT, the ancillary benefits associated with BTM in terms of reduced hospital stay, shorter surgery times, fewer follow-up visits, and lower revisionary surgery rates contribute substantially to overall cost-effectiveness. Biodegradable Temporizing Matrix use reflects more efficient resource use and potential cost savings, aligning with broader trends in healthcare emphasizing value-based and patient-centered care.
https://pubmed.ncbi.nlm.nih.gov/38556669/
The Clinicians Speak, page-845
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.17 |
Change
-0.140(6.06%) |
Mkt cap ! $1.497B | |||
| Open | High | Low | Value | Volume |
| $2.30 | $2.30 | $2.16 | $2.892M | 1.314M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 17906 | $2.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.18 | 13284 | 2 |
View Market Depth
| Last trade - 16.10pm 04/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.17 |
Change
-0.140 ( 5.71 %) |
||||
| Open | High | Low | Volume | ||
| $2.30 | $2.30 | $2.16 | 285639 | ||
| Last updated 15.59pm 04/06/2024 ? | |||||
| PNV (ASX) Chart |